Cancer treatment

Cancer treatment

New Research on Liver Cancer Treatment Reveals Promising Biomarkers for Immunotherapy Selection

A multicenter study conducted at Teine Keijinkai Hospital in Sapporo, Japan, has identified a modified tumor marker score that can help predict treatment outcomes for patients with unresectable hepatocellular carcinoma (HCC). The study, published in the journal Liver Cancer, found that the score, which incorporates alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin

Cancer treatment

Breakthrough in Bladder Cancer Research: Identifying Key Biomarkers for Ferroptosis Resistance and Immunotherapy Response

Researchers at Shaanxi Provincial People's Hospital, in collaboration with other institutions, have made a groundbreaking discovery in the field of bladder cancer. By integrating expression quantitative trait loci (eQTL) data with Mendelian randomization (MR) analysis, the team identified a key biomarker, Tripartite Motif Containing 59 (TRIM59), which plays

Cancer treatment

Breakthrough in Bladder Cancer Research: Identifying Key Biomarkers for Ferroptosis Resistance and Immunotherapy Response

Researchers at Shaanxi Provincial People's Hospital, in collaboration with other institutions, have made a groundbreaking discovery in the field of bladder cancer. By integrating expression quantitative trait loci (eQTL) data with Mendelian randomization (MR) analysis, the team identified a key biomarker, Tripartite Motif Containing 59 (TRIM59), which plays

Cancer treatment

Breakthrough in Cancer Treatment: Researchers Develop Glutathione-Responsive Nanoprodrug

Investigators at Liaocheng University have made a significant discovery in the fight against cancer. A team of researchers, led by Min Hong, has developed a glutathione-responsive amphiphilic camptothecin prodrug, Lc-ss-CPT, which has shown promise in targeted cancer therapy. The prodrug, synthesized by conjugating hydrophobic camptothecin with hydrophilic L-carnitine, self-assembles into